Author:
Morales-Vásquez Flavia,Cano-Blanco Claudia,Coronel-Martínez Jaime Alberto,Cetina-Pérez Lucely,Martínez-Tlahuel Jorge,Velasco-Rodríguez Julio César,López-Basave Horacio N.,de la Garza-Salazar Jaime G.
Publisher
Springer International Publishing
Reference47 articles.
1. Abbe R. The use of radium in malignant disease. Lancet. 1913;2:524.
2. Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med. 1999;340(15):1154–61.
3. Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med. 1999;340:1137–43.
4. Peters WA, Liu PY, Barrett RGW. Cisplatin, 5-Fluorouracil plus radiation therapy are superior to radiation therapy as adjunctive therapy in high risk, early stage carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: report of a Phase III inter group study. Presented at Society of Gynecologic Oncologists 30th annual meeting; San Francisco; 5–9 Feb 1999.
5. Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 1999;340:1144–53.